Target Details
| UniProt AC | P42345 |
|---|---|
| Gene Symbol | MTOR |
| Protein Name | Serine/threonine-protein kinase mTOR |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF02259 (FAT) PF02260 (FATC) PF08771 (FRB_dom) PF23593 (HEAT_ATR) PF11865 (mTOR_dom) PF00454 (PI3_PI4_kinase) |
Summary
- Multi-target molecules 2,517
- Clinical molecules 193
- Avg pChEMBL 7.75
KEGG Pathways (53)
- AMPK signaling pathway
- Acute myeloid leukemia
- Adipocytokine signaling pathway
- Alzheimer disease
- Amyotrophic lateral sclerosis
- Apelin signaling pathway
- Autophagy - animal
- Autophagy - other
- Breast cancer
- Cellular senescence
- Central carbon metabolism in cancer
- Chemical carcinogenesis - receptor activation
- Choline metabolism in cancer
- Colorectal cancer
- Diabetic cardiomyopathy
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- ErbB signaling pathway
- Gastric cancer
- Glioma
- Growth hormone synthesis, secretion and action
- HIF-1 signaling pathway
- Hepatocellular carcinoma
- Herpes simplex virus 1 infection
- Human cytomegalovirus infection
- Human immunodeficiency virus 1 infection
- Human papillomavirus infection
- Huntington disease
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- JAK-STAT signaling pathway
- Kaposi sarcoma-associated herpesvirus infection
- Longevity regulating pathway
- Longevity regulating pathway - multiple species
- Lysosome biogenesis
- MicroRNAs in cancer
- Neutrophil extracellular trap formation
- PD-L1 expression and PD-1 checkpoint pathway in cancer
- PI3K-Akt signaling pathway
- Pancreatic cancer
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Phospholipase D signaling pathway
- Prostate cancer
- Proteoglycans in cancer
- Shigellosis
- Spinocerebellar ataxia
- Th17 cell differentiation
- Thermogenesis
- Thyroid hormone signaling pathway
- Type II diabetes mellitus
- mTOR signaling pathway
Associated Diseases (2)
Active Molecules (2,517)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
DAYJDLKGFSGOQF
|
8.8 | IC50 | 3 | — | |
FEJIEJMRLPNJMJ
|
8.8 | IC50 | 2 | — | |
JWALCFOAEPZSCR
|
8.8 | IC50 | 2 | — | |
JWGVUDPAMQEIJU
|
8.8 | IC50 | 2 | — | |
MRDBTEMVACILBF
|
8.8 | IC50 | 2 | — | |
NARUWMXXZKXDHE
|
8.8 | IC50 | 2 | — | |
PNIRYKZKGDZRPO
|
8.8 | IC50 | 2 | — | |
WIDVWQIEFDGGQO
|
8.8 | IC50 | 2 | — | |
WQBAZXIQANTUOY
|
8.8 | Ki | 4 | — | |
ZLYNTRDYMVVVMZ
|
8.8 | IC50 | 2 | — | |
ZRLCNRCZZGRZFX
|
8.8 | IC50 | 2 | — | |
ZXONVJJRRBXWDX
|
8.8 | IC50 | 3 | — | |
FJRLBVKUYNZNJD
|
8.8 | IC50 | 2 | — | |
ISVITAOPPNXOER
|
8.8 | IC50 | 2 | — | |
KTOUXFUSEFFTIN
|
8.8 | IC50 | 2 | — | |
LZJPWMXFCNFGCA
|
8.8 | Ki | 2 | — | |
SCJNQUFRUCWOQD
|
8.8 | IC50 | 3 | — | |
AIYCRHJZMXDRDI
|
8.8 | pIC50 | 2 | Yes | |
CGYCCKLODGJVER
|
8.8 | IC50 | 2 | — | |
DWZAEMINVBZMHQ
|
8.8 | IC50 | 6 | — | |
FFDWULSGZGFIQJ
|
8.8 | IC50 | 3 | — | |
FZPTZJXAPPIMHT
|
8.8 | IC50 | 2 | — | |
HJLWEROPDBIBIJ
|
8.8 | IC50 | 2 | — | |
HZFUJVGFYOVEHB
|
8.8 | IC50 | 2 | — | |
PHCXCLUQKBHQJU
|
8.8 | IC50 | 3 | — | |
PMUAIGLZZYUTTE
|
8.8 | Ki | 2 | — | |
RTXWPOABAGXULX
|
8.8 | IC50 | 6 | — | |
XKSGMQQGAXYLFE
|
8.8 | pIC50 | 3 | Yes | |
YXQKBQLVKBUCLZ
|
8.8 | Kd | 4 | — | |
IMHVWKMGNNGYDL
|
8.8 | IC50 | 2 | — | |
RBJIANHCYMYEBX
|
8.8 | IC50 | 2 | — | |
UPYIWCUWZHOISR
|
8.8 | IC50 | 2 | — | |
ZEMOOMDUPJIJMM
|
8.8 | IC50 | 2 | — | |
WAUDHZKWWFGTDH
|
8.8 | IC50 | 2 | — | |
AQODXCHGIFZIIO
|
8.8 | IC50 | 3 | — | |
HEVFJNSHEIITJA
|
8.8 | IC50 | 2 | — | |
HTQDGBRDNHEJRY
|
8.8 | IC50 | 2 | — | |
IJAVTPLMQUWYCR
|
8.8 | IC50 | 3 | — | |
IXMCVAWUFQXLOS
|
8.8 | IC50 | 3 | — | |
KFWWZVVPUJJYJC
|
8.8 | IC50 | 3 | — | |
NUUSKGDTQXETAP
|
8.8 | IC50 | 2 | — | |
OVJNWPYSQKFXRB
|
8.8 | IC50 | 2 | — | |
PBPMRYYZVXMZIH
|
8.8 | IC50 | 2 | — | |
QRQHRPXNUZROOQ
|
8.8 | IC50 | 2 | — | |
UHBBECJRCILYHF
|
8.8 | Ki | 3 | — | |
UMANUGUGHDROEQ
|
8.8 | IC50 | 2 | — | |
VIZDWFMDXKHPJD
|
8.8 | IC50 | 2 | — | |
VXCYNHOBTVMSEN
|
8.8 | IC50 | 2 | — | |
WJLXKJVDEMAVDD
|
8.8 | Ki | 2 | — | |
FDWYRWDMLCDEJO
|
8.8 | Ki | 2 | — |